SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-003728
Filing Date
2015-07-08
Accepted
2015-07-08 06:45:20
Documents
19
Period of Report
2015-07-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_070815.htm 8-K 19397
2 EXHIBIT 99.1 exh_991.htm EX-99.1 17970
3 exh991_01.jpg GRAPHIC 124824
4 exh991_02.jpg GRAPHIC 205513
5 exh991_03.jpg GRAPHIC 153104
6 exh991_04.jpg GRAPHIC 160191
7 exh991_05.jpg GRAPHIC 158643
8 exh991_06.jpg GRAPHIC 150996
9 exh991_07.jpg GRAPHIC 163670
10 exh991_08.jpg GRAPHIC 155634
11 exh991_09.jpg GRAPHIC 149709
12 exh991_10.jpg GRAPHIC 146614
13 exh991_11.jpg GRAPHIC 162067
14 exh991_12.jpg GRAPHIC 146502
15 exh991_13.jpg GRAPHIC 137415
16 exh991_14.jpg GRAPHIC 184951
17 exh991_15.jpg GRAPHIC 151964
18 exh991_16.jpg GRAPHIC 164229
19 exh991_17.jpg GRAPHIC 153134
  Complete submission text file 0001171843-15-003728.txt   3717993
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 15977774
SIC: 2834 Pharmaceutical Preparations